Literature DB >> 2898464

A soluble-factor(s) secreted by a human skin cancer cell line supports clonal growth of adult T-cell leukemia cells.

Y Kagami1, T Kinoshita, M Shimoyama, M Miwa.   

Abstract

Leukemic cells from four out of eight patients with adult T-cell leukemia (ATL) were successfully grown by cocultivation with HSC-I cells, a human skin cancer cell line, in the presence of interleukin-2. Three of these four cultures of growing cells showed rearrangement of the T-cell receptor beta-chain gene like the original leukemic cells in vivo, and also showed conservation of the patterns of HTLV-I integration of the original leukemic cells in vivo. Cell-to-cell contact between HSC-I cells and leukemic cells was not necessary for growth of the leukemic cells. The results indicate that some soluble growth factor secreted by HSC-I cells and interleukin-2 are required for the in vitro growth of leukemic cells from some patients with adult T-cell leukemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898464      PMCID: PMC5917511          DOI: 10.1111/j.1349-7006.1988.tb01608.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  12 in total

1.  Lymphocyte traffic, T-cell malignancies and the skin.

Authors:  J W Streilein
Journal:  J Invest Dermatol       Date:  1978-09       Impact factor: 8.551

2.  Sequence and expression of transcripts of the human T-cell receptor beta-chain genes.

Authors:  Y Yoshikai; D Anatoniou; S P Clark; Y Yanagi; R Sangster; P Van den Elsen; C Terhorst; T W Mak
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

3.  Adult T-cell leukemia/lymphoma not associated with human T-cell leukemia virus type I.

Authors:  M Shimoyama; Y Kagami; K Shimotohno; M Miwa; K Minato; K Tobinai; K Suemasu; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease.

Authors:  M Yoshida; M Seiki; K Yamaguchi; K Takatsuki
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

5.  Keratinocyte-derived T-cell growth factor: a T-cell growth factor functionally distinct from interleukin 2.

Authors:  T S Kupper; D L Coleman; J McGuire; D Goldminz; M C Horowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  A T-cell line derived from normal human cord leukocytes by co-culturing with human leukemic T-cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; Y Shiraishi
Journal:  Gan       Date:  1981-12

7.  Establishment and characterization of 10 cell lines derived from patients with adult T-cell leukemia.

Authors:  H Hoshino; H Esumi; M Miwa; M Shimoyama; K Minato; K Tobinai; M Hirose; S Watanabe; N Inada; K Kinoshita; S Kamihira; M Ichimaru; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

8.  Epidermal cells synthesize a cytokine with interleukin 3-like properties.

Authors:  T A Luger; U Wirth; A Köck
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

9.  Configuration and expression of the T cell receptor beta chain gene in human T-lymphotrophic virus I-infected cells.

Authors:  R F Jarrett; H Mitsuya; D L Mann; J Cossman; S Broder; M S Reitz
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

10.  Origin of human T-lymphotrophic virus I-positive T cell lines in adult T cell leukemia. Analysis of T cell receptor gene rearrangement.

Authors:  M Maeda; A Shimizu; K Ikuta; H Okamoto; M Kashihara; T Uchiyama; T Honjo; J Yodoi
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

View more
  1 in total

1.  Molecular cloning and characterization of a cDNA for a novel phorbol-12-myristate-13-acetate-responsive gene that is highly expressed in an adult T-cell leukemia cell line.

Authors:  M Hijikata; N Kato; T Sato; Y Kagami; K Shimotohno
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.